These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 36608868

  • 1. RBM10 recruits METTL3 to induce N6-methyladenosine-MALAT1-dependent modification, inhibiting the invasion and migration of NSCLC.
    Cao Y, Di X, Cong S, Tian C, Wang Y, Jin X, Zhao M, Zhou X, Li R, Wang K.
    Life Sci; 2023 Feb 15; 315():121359. PubMed ID: 36608868
    [Abstract] [Full Text] [Related]

  • 2. m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.
    Jin D, Guo J, Wu Y, Du J, Yang L, Wang X, Di W, Hu B, An J, Kong L, Pan L, Su G.
    J Hematol Oncol; 2019 Dec 09; 12(1):135. PubMed ID: 31818312
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. c-MYC/METTL3/LINC01006 positive feedback loop promotes migration, invasion and proliferation of non-small cell lung cancer.
    Liu C, Ren Q, Deng J, Wang S, Ren L.
    Biomed J; 2024 Aug 09; 47(4):100664. PubMed ID: 37774794
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
    Li D, Fu Z, Dong C, Song Y.
    Bioengineered; 2022 Apr 09; 13(4):10493-10503. PubMed ID: 35441574
    [Abstract] [Full Text] [Related]

  • 8. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer.
    Li S, Jiang F, Chen F, Deng Y, Pan X.
    J Biochem Mol Toxicol; 2022 Jan 09; 36(1):e22922. PubMed ID: 34964205
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. METTL3 Mediated MALAT1 m6A Modification Promotes Proliferation and Metastasis in Osteosarcoma Cells.
    Zhang Y, Xu Y, Qiu G, Luo Y, Bao Y, Lu J, Wang T, Wang Y.
    Mol Biotechnol; 2024 Dec 09; 66(12):3538-3548. PubMed ID: 37897586
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. RBM10 regulates alternative splicing of lncRNA Neat1 to inhibit the invasion and metastasis of NSCLC.
    Cong S, Di X, Li R, Cao Y, Jin X, Tian C, Zhao M, Wang K.
    Cancer Cell Int; 2022 Nov 05; 22(1):338. PubMed ID: 36335386
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.
    Lin C, Li T, Wang Y, Lai S, Huang Y, Guo Z, Zhang X, Weng S.
    Cell Death Dis; 2023 Mar 28; 14(3):221. PubMed ID: 36977668
    [Abstract] [Full Text] [Related]

  • 15. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.
    Cui S.
    J Clin Lab Anal; 2022 Dec 28; 36(12):e24761. PubMed ID: 36336887
    [Abstract] [Full Text] [Related]

  • 16. Methyltransferase-like 3 promotes the progression of lung cancer via activating PI3K/AKT/mTOR pathway.
    Cheng FW, Peng LM, Luo D.
    Clin Exp Pharmacol Physiol; 2022 Jul 28; 49(7):748-758. PubMed ID: 35434840
    [Abstract] [Full Text] [Related]

  • 17. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
    Bi X, Lv X, Liu D, Guo H, Yao G, Wang L, Liang X, Yang Y.
    Cancer Gene Ther; 2021 Apr 28; 28(3-4):335-349. PubMed ID: 32939058
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X, Wang Z, Lu W, Miao L, Zhao Y.
    BMC Pulm Med; 2022 Aug 25; 22(1):324. PubMed ID: 36008805
    [Abstract] [Full Text] [Related]

  • 20. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
    Liu X, Xiao M, Zhang L, Li L, Zhu G, Shen E, Lv M, Lu X, Sun Z.
    J Clin Lab Anal; 2021 Mar 25; 35(3):e23655. PubMed ID: 33314339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.